Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Omeros Corp (OMER)

21.3 0.51 (2.45%)

05-22 09:59

Open:

21.04

Pre. Close:

20.79

High:

21.97

Low:

20.8

Volume:

250,793

Market Cap:

1029M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

21.09 - 21.192

21.192 - 21.28

Low:

19.822 - 19.937

19.937 - 20.036

Close:

20.614 - 20.796

20.796 - 20.954

Technical analysis  (as of: 2018-05-21 4:32:11 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 29.43     One year: 34.38

Support:

Support1: 18.07    Support2: 13.66

Resistance:

Resistance1: 25.20    Resistance2: 29.43

Pivot:

18.32

Moving Averages:

MA(5): 21.12     MA(20): 17.34

MA(100): 14.83     MA(250): 17.87

MACD:

MACD(12,26): 1.92     Signal(12,26,9): 1.61

%K %D:

%K(14,3): 56.47     %D(3): 59.70

RSI:

RSI(14): 62.94

52-Week:

High: 27.09  Low: 8.36  Change(%): 31.2

Average Vol(K):

3-Month: 153347  10-Days 212160

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
OMER has closed below upper band by 28.9%. Bollinger Bands are 160.3% wider than normal. The large width of the bands suggest high volatility as compared to OMER's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

2018-05-18T05:43:57-04:00
Omeros Corporation: What Do The Q1 2018 Earnings Foretell?

2018-05-16T13:00:10-04:00
Midday Gainers / Losers (05/16/2018)

2018-05-16T06:38:09-04:00
Rounds Report: Omeros Rallied Robustly While Stellar FDA Due Diligence To Help Orphan Disease Innovators

2018-05-16T03:55:30-04:00
Lucky Seven: Immune Design Takes Off, Institutions Place Bets On Viking Therapeutics

2018-05-14T10:00:00-04:00
Your Daily Pharma Scoop: Omeros Up On Update, Synergy Sales, President's Healthcare Plans

2018-05-14T08:19:53-04:00
Lucky Seven: Achaogen Likely To Bounce Back

2018-05-13T03:46:04-04:00
Rounds Report: Omeros Rallied While Stellar FDA Due Diligence To Help Atara Biotherapeutics

2018-05-12T00:23:51-04:00
Lucky Seven: Omeros Pops, Exelixis Drops On Phase 3 Flop

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

48.29

Shares Float (M)

45.74

% Held by Insiders

5.30

% Held by Institutions

50.20

Shares Short (K)

10555

Shares Short Prior Month (K)

8140

Stock Financials

EPS

-1.080

EPS Est. Current Year

-1.300

EPS Est. Next Year

-0.700

EPS Est. Next Quarter

-0.310

Forward EPS

-0.840

Book Value (p.s.)

52.950

PEG Ratio

-0.10

Profit Margin

-73.03

Operating Margin

-67.71

Return on Assets (ttm)

-58.3

Return on Equity (ttm)

265.7

Qtrly Rev. Growth

6.6

Gross Profit (p.s.)

0.797

Sales Per Share

EBITDA (p.s.)

-0.333

Qtrly Earnings Growth

Operating Cash Flow (M)

-36.23

Levered Free Cash Flow (M)

-21.19

atoplab.com

Valuation

P/E

-19.25

P/E Growth Ratio

0.03

P/BV

0.39

P/S

707006464.00

P/CF

-27.71

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.